,reactionoutcome,reactionmeddraversionpt,reactionmeddrapt,safetyreportid
0,5,22.1,Death,16873454
1,6,22.1,General physical health deterioration,16873454
0,6,22.1,Malaise,16873483
1,6,22.1,Dehydration,16873483
2,6,22.1,Decreased appetite,16873483
3,6,22.1,Weight increased,16873483
4,6,22.1,Dizziness,16873483
5,6,22.1,Nausea,16873483
6,2,22.1,Fatigue,16873483
7,6,22.1,Hot flush,16873483
0,3,22.1,Alopecia,16873484
1,3,22.1,Hair texture abnormal,16873484
2,3,22.1,Hair colour changes,16873484
3,3,22.1,Hair disorder,16873484
4,3,22.1,Madarosis,16873484
0,6,22.1,Full blood count decreased,16873485
1,3,22.1,Constipation,16873485
2,6,22.1,Hot flush,16873485
3,6,22.1,Nausea,16873485
4,6,22.1,Nerve injury,16873485
5,6,22.1,Neuralgia,16873485
6,6,22.1,Salivary hypersecretion,16873485
7,6,22.1,Dry mouth,16873485
0,3,22.1,Alopecia,16873489
1,3,22.1,Hair disorder,16873489
2,3,22.1,Anxiety,16873489
3,3,22.1,Hair texture abnormal,16873489
4,3,22.1,Hair colour changes,16873489
0,5,22.1,Renal failure,16873500
1,6,22.1,Intentional product misuse,16873500
0,6,22.1,White blood cell count decreased,16873505
0,1,22.1,Ventricular extrasystoles,16873521
0,3,22.1,Hair injury,16873534
1,3,22.1,Madarosis,16873534
2,3,22.1,Alopecia,16873534
3,3,22.1,Hair colour changes,16873534
4,3,22.1,Hair texture abnormal,16873534
5,3,22.1,Hair disorder,16873534
0,1,22.1,Diarrhoea,16873539
1,3,22.1,Decreased appetite,16873539
2,1,22.1,Blood phosphorus decreased,16873539
3,3,22.1,Nausea,16873539
4,1,22.1,Vomiting,16873539
0,,22.1,Tumour ulceration,16873566
1,,22.1,Skin ulcer haemorrhage,16873566
2,,22.1,Off label use,16873566
0,6,22.1,Inappropriate schedule of product administration,16873578
1,2,22.1,Aspartate aminotransferase increased,16873578
2,6,22.1,Renal impairment,16873578
3,6,22.1,Asthenia,16873578
4,6,22.1,Mobility decreased,16873578
5,6,22.1,Fatigue,16873578
6,2,22.1,Alanine aminotransferase increased,16873578
7,6,22.1,Malignant neoplasm progression,16873578
8,6,22.1,Amnesia,16873578
9,6,22.1,Hepatic function abnormal,16873578
0,5,22.1,Death,16873628
0,6,22.1,Feeling abnormal,16873633
1,6,22.1,Headache,16873633
2,6,22.1,Fatigue,16873633
0,6,22.1,Paraesthesia oral,16873643
1,6,22.1,Taste disorder,16873643
0,6,22.1,Hallucination,16873647
1,6,22.1,Off label use,16873647
0,6,22.1,Treatment noncompliance,16873672
1,2,22.1,Prostatic specific antigen increased,16873672
2,1,22.1,Thrombocytopenia,16873672
3,1,22.1,Disseminated intravascular coagulation,16873672
4,1,22.1,Haematuria,16873672
0,1,22.1,Depression,16873694
1,1,22.1,Arthralgia,16873694
2,1,22.1,Anxiety,16873694
3,6,22.1,Product substitution issue,16873694
4,1,22.1,Pain,16873694
5,1,22.1,Mental status changes,16873694
0,5,22.1,Malignant neoplasm progression,16873721
0,6,22.1,Colitis ulcerative,16873740
0,6,22.1,Product dose omission,16873748
1,6,22.1,Inflammation,16873748
2,3,22.1,Increased appetite,16873748
3,3,22.1,Dizziness,16873748
4,3,22.1,Headache,16873748
5,3,22.1,Dysgeusia,16873748
6,3,22.1,Anaemia,16873748
7,3,22.1,Dyspnoea,16873748
0,1,22.1,Hypersensitivity,16873768
1,6,22.1,Back pain,16873768
2,6,22.1,Feeling cold,16873768
3,6,22.1,Chills,16873768
0,1,22.1,Dysphagia,16873791
0,6,22.1,Breast cancer metastatic,16873798
1,1,22.1,Diarrhoea,16873798
2,1,22.1,Hypokalaemia,16873798
3,6,22.1,Off label use,16873798
0,6,22.1,Headache,16873821
1,6,22.1,Platelet count decreased,16873821
2,6,22.1,Nausea,16873821
3,6,22.1,Dyspnoea,16873821
4,6,22.1,Fatigue,16873821
5,5,22.1,Death,16873821
6,6,22.1,Diarrhoea,16873821
7,6,22.1,Haemoglobin decreased,16873821
8,6,22.1,Faeces discoloured,16873821
0,3,22.1,Abdominal pain,16873823
1,3,22.1,Dyspepsia,16873823
2,3,22.1,Sinus congestion,16873823
3,3,22.1,Lower respiratory tract infection,16873823
4,3,22.1,Upper respiratory tract infection,16873823
5,3,22.1,Headache,16873823
6,3,22.1,Constipation,16873823
7,3,22.1,Dyspnoea,16873823
8,3,22.1,Upper respiratory tract congestion,16873823
9,3,22.1,Blood pressure increased,16873823
10,3,22.1,Blood pressure systolic increased,16873823
11,3,22.1,Hordeolum,16873823
12,3,22.1,Oral herpes,16873823
13,3,22.1,Nausea,16873823
14,3,22.1,Pain,16873823
15,3,22.1,Hypertension,16873823
16,3,22.1,Fatigue,16873823
17,3,22.1,Nasopharyngitis,16873823
18,3,22.1,Oropharyngeal pain,16873823
19,3,22.1,Weight fluctuation,16873823
20,3,22.1,Drug ineffective,16873823
21,3,22.1,Cough,16873823
22,3,22.1,Epistaxis,16873823
23,3,22.1,Asthenia,16873823
24,3,22.1,Hypotension,16873823
25,3,22.1,Cellulitis,16873823
26,3,22.1,Eye infection,16873823
27,3,22.1,Rhinorrhoea,16873823
0,1,22.1,Thrombocytopenia,16873839
1,1,22.1,Lung disorder,16873839
0,6,22.1,Gastrointestinal haemorrhage,16873845
1,6,22.1,Pulmonary embolism,16873845
2,6,22.1,Diabetes mellitus,16873845
3,6,22.1,Fatigue,16873845
4,6,22.1,Aphonia,16873845
5,6,22.1,Thyroid function test abnormal,16873845
6,6,22.1,Product packaging difficult to open,16873845
7,6,22.1,Hypertension,16873845
8,6,22.1,Renal disorder,16873845
0,3,22.1,Arrhythmia,16873940
1,3,22.1,Syncope,16873940
2,3,22.1,Ejection fraction decreased,16873940
0,2,22.1,White blood cell count decreased,16873958
0,6,22.1,Fatigue,16873966
0,6,22.1,Neoplasm progression,16873968
1,2,22.1,Arthralgia,16873968
2,2,22.1,Back pain,16873968
0,5,22.1,Death,16873979
1,6,22.1,Malignant neoplasm progression,16873979
0,3,22.1,Neck pain,16874016
1,6,22.1,Deafness,16874016
2,3,22.1,Nausea,16874016
3,6,22.1,Pain in extremity,16874016
4,2,22.1,Pruritus,16874016
5,6,22.1,Neuropathy peripheral,16874016
6,3,22.1,Oropharyngeal pain,16874016
7,6,22.1,Bronchitis,16874016
8,6,22.1,Urinary tract infection,16874016
9,6,22.1,Dizziness,16874016
10,3,22.1,Paraesthesia,16874016
11,2,22.1,Rash,16874016
12,6,22.1,Constipation,16874016
13,6,22.1,Stomatitis,16874016
14,6,22.1,Insomnia,16874016
15,6,22.1,Glossodynia,16874016
16,6,22.1,Chest pain,16874016
17,6,22.1,Tinnitus,16874016
18,3,22.1,Ear pain,16874016
19,6,22.1,Pain in jaw,16874016
20,6,22.1,Blood pressure abnormal,16874016
21,6,22.1,Fatigue,16874016
22,3,22.1,Oral pain,16874016
23,3,22.1,Back pain,16874016
24,6,22.1,Decreased appetite,16874016
25,6,22.1,White blood cell count decreased,16874016
0,2,22.1,Dizziness,16874023
1,2,22.1,Malaise,16874023
2,3,22.1,Arthralgia,16874023
3,3,22.1,Pain,16874023
0,6,22.1,Mesenteric neoplasm,16874039
1,6,22.1,Duodenal stenosis,16874039
2,6,22.1,Tumour marker increased,16874039
3,6,22.1,Carcinoembryonic antigen increased,16874039
4,6,22.1,Metastases to lymph nodes,16874039
5,6,22.1,Metastases to bone,16874039
6,6,22.1,Metastases to liver,16874039
7,6,22.1,Metastases to peritoneum,16874039
8,6,22.1,Intestinal congestion,16874039
9,6,22.1,Urinary retention,16874039
0,3,22.1,Diabetes mellitus,16874058
1,1,22.1,Stomatitis,16874058
2,3,22.1,Drug ineffective,16874058
3,1,22.1,Skin discolouration,16874058
4,1,22.1,Dysuria,16874058
5,1,22.1,Proctitis,16874058
6,3,22.1,Metastatic neoplasm,16874058
7,1,22.1,Weight decreased,16874058
8,1,22.1,Hypersensitivity,16874058
9,1,22.1,Mouth ulceration,16874058
10,3,22.1,Hypertension,16874058
11,1,22.1,Gastritis,16874058
0,6,22.1,Atelectasis,16874059
1,6,22.1,Pneumonitis,16874059
0,6,22.1,Weight increased,16874090
1,6,22.1,Increased appetite,16874090
0,5,22.1,Death,16874114
0,3,22.1,Respiratory disorder,16874124
1,3,22.1,Chronic obstructive pulmonary disease,16874124
2,,22.1,Off label use,16874124
3,3,22.1,Rash,16874124
4,3,22.1,Asthma,16874124
5,,22.1,Product use in unapproved indication,16874124
6,3,22.1,Pruritus,16874124
0,,22.1,Nausea,16874149
1,,22.1,Abdominal pain,16874149
2,,22.1,Vomiting,16874149
0,5,22.1,Drug resistance,16874168
1,5,22.1,Metastasis,16874168
0,1,22.1,Pyrexia,16874180
1,1,22.1,Seizure,16874180
2,4,22.1,Atrioventricular block second degree,16874180
3,6,22.1,Sinus arrest,16874180
4,6,22.1,Altered state of consciousness,16874180
0,1,22.1,Hypotension,16874206
1,1,22.1,Infection,16874206
2,6,22.1,Neck pain,16874206
3,6,22.1,Depressed mood,16874206
4,1,22.1,Surgery,16874206
5,1,22.1,Taste disorder,16874206
6,3,22.1,Platelet count decreased,16874206
7,6,22.1,Abdominal pain upper,16874206
0,6,22.1,Hyponatraemia,16874219
0,6,22.1,Neurotoxicity,16874226
1,3,22.1,Off label use,16874226
0,6,22.1,Asthenia,16874240
1,3,22.1,Headache,16874240
2,3,22.1,Malaise,16874240
3,3,22.1,Nausea,16874240
4,3,22.1,Fatigue,16874240
5,6,22.1,White blood cell count decreased,16874240
6,1,22.1,Platelet count decreased,16874240
7,6,22.1,Bone marrow disorder,16874240
8,3,22.1,Abdominal pain,16874240
9,3,22.1,Insomnia,16874240
10,6,22.1,Red blood cell count decreased,16874240
11,1,22.1,Joint swelling,16874240
12,6,22.1,Drug intolerance,16874240
0,5,22.1,Death,16874260
1,6,22.1,Acute respiratory failure,16874260
0,5,22.1,Pneumonitis,16874271
0,6,22.1,Acute kidney injury,16874275
0,5,22.1,Lung adenocarcinoma,16874305
1,5,22.1,Lymphangiosis carcinomatosa,16874305
2,2,22.1,Interstitial lung disease,16874305
0,5,22.1,Death,16874316
0,4,22.1,Epistaxis,16874321
1,6,22.1,Haematotoxicity,16874321
2,6,22.1,Toxicity to various agents,16874321
3,6,22.1,Thrombocytopenia,16874321
4,1,22.1,Nausea,16874321
5,6,22.1,Pain,16874321
6,6,22.1,Drug intolerance,16874321
7,6,22.1,Stomatitis,16874321
8,6,22.1,Product use in unapproved indication,16874321
9,1,22.1,Hypertrichosis,16874321
10,6,22.1,Neuropathy peripheral,16874321
11,6,22.1,Dermatitis acneiform,16874321
12,6,22.1,Thrombocytopenia,16874321
13,6,22.1,Herpes simplex,16874321
14,1,22.1,Rash,16874321
15,1,22.1,Thrombocytopenia,16874321
16,1,22.1,Anaemia,16874321
0,6,22.1,Muscular weakness,16874350
1,6,22.1,Dehydration,16874350
2,5,22.1,Respiratory failure,16874350
3,6,22.1,Pneumonia,16874350
4,6,22.1,Neutropenia,16874350
5,5,22.1,Pleural effusion,16874350
6,6,22.1,Hypocalcaemia,16874350
0,5,22.1,Haemorrhage intracranial,16874364
1,6,22.1,Hypomagnesaemia,16874364
2,6,22.1,Headache,16874364
0,6,22.1,Breast cancer,16874374
1,6,22.1,Off label use,16874374
0,6,22.1,Vitreoretinal traction syndrome,16874379
1,6,22.1,Retinal oedema,16874379
2,6,22.1,Macular fibrosis,16874379
0,1,22.1,Vascular pseudoaneurysm,16874380
0,6,22.1,Skin necrosis,16874397
1,6,22.1,Off label use,16874397
2,6,22.1,Skin wound,16874397
0,6,22.1,Anaemia,16874447
1,6,22.1,Neoplasm progression,16874447
2,6,22.1,Drug ineffective,16874447
0,6,22.1,Product dose omission,16874454
1,6,22.1,Product use in unapproved indication,16874454
2,3,22.1,Thrombosis,16874454
3,3,22.1,Gastric infection,16874454
0,6,22.1,Drug resistance,16874484
0,6,22.1,Off label use,16874486
1,3,22.1,Proctalgia,16874486
2,3,22.1,Frequent bowel movements,16874486
3,3,22.1,Back pain,16874486
4,3,22.1,Abdominal pain upper,16874486
0,6,22.1,Infection,16874492
0,5,22.1,Respiratory failure,16874494
1,6,22.1,Abdominal cavity drainage,16874494
2,6,22.1,Blood pressure decreased,16874494
3,6,22.1,Tumour haemorrhage,16874494
4,5,22.1,Interstitial lung disease,16874494
5,6,22.1,Melaena,16874494
6,6,22.1,Depressed level of consciousness,16874494
0,5,22.1,Malignant neoplasm progression,16874561
1,5,22.1,Drug resistance,16874561
0,1,22.1,Immune thrombocytopenic purpura,16874573
0,6,22.1,Myelodysplastic syndrome,16874598
1,6,22.1,Pancytopenia,16874598
2,6,22.1,Acute myeloid leukaemia,16874598
0,2,22.1,Hypotension,16874613
1,1,22.1,Renal cyst,16874613
2,6,22.1,Heparin-induced thrombocytopenia,16874613
3,2,22.1,Diarrhoea,16874613
0,1,22.1,Lip swelling,16874629
1,1,22.1,Chills,16874629
2,1,22.1,Tinnitus,16874629
3,1,22.1,Paraesthesia,16874629
0,3,22.1,Stomatitis,16874656
1,3,22.1,Malaise,16874656
2,6,22.1,Cholecystitis infective,16874656
3,6,22.1,Lip exfoliation,16874656
4,3,22.1,Gallbladder rupture,16874656
5,3,22.1,Weight decreased,16874656
0,2,22.1,Osteonecrosis of jaw,16874665
1,6,22.1,Product use in unapproved indication,16874665
0,3,22.1,Malignant neoplasm progression,16874681
1,1,22.1,Epistaxis,16874681
0,6,22.1,Anaemia,16874711
1,6,22.1,Malignant neoplasm progression,16874711
2,6,22.1,Complication associated with device,16874711
3,6,22.1,Prostatic specific antigen increased,16874711
4,5,22.1,Death,16874711
0,5,22.1,Death,16874722
1,6,22.1,Haemoglobin decreased,16874722
2,6,22.1,Restlessness,16874722
3,6,22.1,Back pain,16874722
4,6,22.1,Blood alkaline phosphatase increased,16874722
5,6,22.1,Hypophagia,16874722
6,6,22.1,Asthenia,16874722
7,6,22.1,White blood cell count decreased,16874722
8,6,22.1,Nausea,16874722
9,6,22.1,Pyrexia,16874722
10,3,22.1,Liver disorder,16874722
11,6,22.1,Insomnia,16874722
12,6,22.1,Constipation,16874722
13,3,22.1,Jaundice,16874722
0,6,22.1,Weight decreased,16874726
1,6,22.1,Decreased appetite,16874726
2,6,22.1,Urinary tract infection,16874726
3,6,22.1,Decreased activity,16874726
4,6,22.1,Malaise,16874726
5,6,22.1,Joint swelling,16874726
6,6,22.1,White blood cell count decreased,16874726
7,6,22.1,Decreased immune responsiveness,16874726
8,6,22.1,Metastases to spine,16874726
9,6,22.1,Fatigue,16874726
10,6,22.1,Eating disorder,16874726
11,6,22.1,Pollakiuria,16874726
12,6,22.1,Back pain,16874726
13,6,22.1,Dysuria,16874726
0,1,22.1,Osteonecrosis of jaw,16874798
0,2,22.1,Face oedema,16874825
1,2,22.1,Oral mucosal erythema,16874825
2,2,22.1,Facial pain,16874825
0,6,22.1,Peripheral swelling,16874870
1,6,22.1,Anxiety,16874870
2,6,22.1,Disorientation,16874870
3,1,22.1,Vomiting,16874870
4,6,22.1,Haemoptysis,16874870
5,1,22.1,Nausea,16874870
6,6,22.1,Confusional state,16874870
7,6,22.1,Overdose,16874870
8,6,22.1,Stress,16874870
0,1,22.1,Nausea,16874871
1,5,22.1,Large intestine perforation,16874871
2,1,22.1,Face oedema,16874871
3,1,22.1,Stomatitis,16874871
0,3,22.1,Visual impairment,16874888
1,3,22.1,Vision blurred,16874888
0,6,22.1,Nausea,16874942
0,6,22.1,Hot flush,16874947
0,3,22.1,Infection,16874965
1,3,22.1,Off label use,16874965
0,6,22.1,Pulmonary tuberculosis,16875215
1,1,22.1,Diarrhoea,16875215
0,6,22.1,Malignant neoplasm progression,16875251
1,6,22.1,Drug resistance,16875251
0,6,22.1,PIK3CA-activated mutation,16875356
1,6,22.1,Breast cancer metastatic,16875356
2,6,22.1,Vertigo,16875356
3,6,22.1,Malignant neoplasm progression,16875356
4,6,22.1,Rash maculo-papular,16875356
5,6,22.1,Metastases to spinal cord,16875356
0,6,22.1,Oesophageal ulcer haemorrhage,16875370
1,6,22.1,Ascites,16875370
2,6,22.1,Portal hypertension,16875370
3,6,22.1,Hepatic necrosis,16875370
4,6,22.1,Duodenal ulcer haemorrhage,16875370
0,5,22.1,Death,16875477
1,1,22.1,Subileus,16875477
0,1,22.1,Chest discomfort,16875494
1,1,22.1,Dyspnoea,16875494
2,6,22.1,Metastases to liver,16875494
3,1,22.1,Pain,16875494
4,1,22.1,Infusion related reaction,16875494
5,1,22.1,Wheezing,16875494
6,6,22.1,Malignant neoplasm progression,16875494
7,6,22.1,Metastases to lung,16875494
0,5,22.1,Pneumonia,16875519
1,3,22.1,Autoimmune myositis,16875519
2,6,22.1,Pulmonary mass,16875519
3,6,22.1,Dyslalia,16875519
4,6,22.1,Peripheral artery thrombosis,16875519
5,6,22.1,Dysphagia,16875519
0,5,22.1,Death,16875523
0,6,22.1,Diarrhoea,16875562
1,3,22.1,Pyrexia,16875562
2,6,22.1,Vomiting,16875562
3,6,22.1,Abdominal rigidity,16875562
4,1,22.1,Gastroenteritis,16875562
0,6,22.1,Device related infection,16875588
1,3,22.1,Rash,16875588
2,6,22.1,Feeling abnormal,16875588
3,6,22.1,Off label use,16875588
4,3,22.1,Rhinitis,16875588
5,3,22.1,Pseudomonas infection,16875588
0,6,22.1,Ejection fraction decreased,16875733
0,,22.1,Death,16875907
0,,22.1,Abdominal pain,16875916
1,,22.1,Diarrhoea,16875916
0,1,22.1,White blood cell count decreased,16876127
1,1,22.1,Hypertension,16876127
0,3,22.1,Liver function test decreased,16876337
0,5,22.1,Prostate cancer,16876373
1,1,22.1,Induration,16876373
2,1,22.1,Erythema,16876373
3,5,22.1,Metastases to bone,16876373
4,6,22.1,Wrong technique in product usage process,16876373
0,2,22.1,Lupus-like syndrome,16876402
0,1,22.1,Diarrhoea,16876427
1,3,22.1,Vomiting,16876427
0,,22.1,Femur fracture,16876432
1,,22.1,Fall,16876432
2,,22.1,Osteogenesis imperfecta,16876432
0,5,22.1,Death,16876473
1,6,22.1,Pathological fracture,16876473
2,6,22.1,Hypercalcaemia,16876473
3,6,22.1,Spinal cord compression,16876473
0,1,22.1,Gastrointestinal haemorrhage,16876483
1,1,22.1,Bone marrow failure,16876483
0,5,22.1,Death,16876510
1,6,22.1,Febrile neutropenia,16876510
0,6,22.1,Malignant neoplasm progression,16876550
1,6,22.1,Drug resistance,16876550
0,1,22.1,Thrombocytopenia,16876600
1,1,22.1,Diarrhoea,16876600
2,1,22.1,Chills,16876600
0,1,22.1,Hyperthyroidism,16876607
1,2,22.1,Immune-mediated adverse reaction,16876607
2,2,22.1,Headache,16876607
3,2,22.1,Paraneoplastic syndrome,16876607
4,2,22.1,Muscle disorder,16876607
5,2,22.1,Discomfort,16876607
6,2,22.1,Myasthenic syndrome,16876607
7,1,22.1,Myasthenia gravis,16876607
8,2,22.1,Myasthenic syndrome,16876607
0,3,22.1,Arthralgia,16876608
1,3,22.1,Joint swelling,16876608
2,3,22.1,Gait inability,16876608
3,3,22.1,Peripheral swelling,16876608
0,1,22.1,Headache,16876631
1,1,22.1,Hypertensive crisis,16876631
2,1,22.1,Cough,16876631
0,,22.1,Infusion related reaction,16876636
1,,22.1,Pruritus,16876636
0,6,22.1,Lymphadenopathy,16876639
1,6,22.1,Leukopenia,16876639
2,6,22.1,Metastases to liver,16876639
3,6,22.1,Rash pustular,16876639
4,6,22.1,Polyneuropathy,16876639
5,6,22.1,Neutropenia,16876639
0,5,22.1,Death,16876641
1,,22.1,Palmar-plantar erythrodysaesthesia syndrome,16876641
2,,22.1,Off label use,16876641
3,3,22.1,Haematemesis,16876641
4,3,22.1,Malaise,16876641
0,2,22.1,Pneumonitis,16876655
0,6,22.1,Product dose omission,16876676
1,6,22.1,Pain in jaw,16876676
2,6,22.1,Malaise,16876676
0,3,22.1,Fatigue,16876680
1,3,22.1,Agitation,16876680
2,6,22.1,Hospitalisation,16876680
3,6,22.1,Carbohydrate antigen 125 increased,16876680
4,2,22.1,Heart valve replacement,16876680
5,6,22.1,Vomiting,16876680
0,1,22.1,Platelet count decreased,16876681
1,6,22.1,Headache,16876681
2,3,22.1,Night sweats,16876681
3,6,22.1,Anaemia,16876681
4,5,22.1,Metastases to lung,16876681
5,6,22.1,Pleural effusion,16876681
6,2,22.1,Vision blurred,16876681
0,6,22.1,Loss of consciousness,16876683
1,6,22.1,Abdominal pain upper,16876683
2,6,22.1,Fatigue,16876683
0,3,22.1,Tachycardia,16876734
1,3,22.1,Ventricular extrasystoles,16876734
0,5,22.1,Death,16876747
0,6,22.1,Hip fracture,16876757
1,6,22.1,Intentional product use issue,16876757
2,6,22.1,Off label use,16876757
0,2,22.1,Bronchospasm,16876758
1,2,22.1,Respiratory failure,16876758
2,2,22.1,Tachycardia,16876758
3,2,22.1,Hypertension,16876758
0,6,22.1,Metastases to meninges,16876798
0,,22.1,Disease progression,16876807
0,,22.1,Disease progression,16876809
0,3,22.1,Pain,16876814
1,6,22.1,Weight decreased,16876814
0,6,22.1,Drug interaction,16876820
1,5,22.1,Acinetobacter infection,16876820
2,6,22.1,Thrombocytopenia,16876820
3,6,22.1,Acute kidney injury,16876820
4,5,22.1,Prerenal failure,16876820
5,1,22.1,Diarrhoea,16876820
6,6,22.1,Hypophagia,16876820
7,6,22.1,Nausea,16876820
8,6,22.1,Dehydration,16876820
9,5,22.1,Sepsis,16876820
10,2,22.1,Vomiting,16876820
11,5,22.1,Neutropenia,16876820
12,5,22.1,Leukopenia,16876820
0,6,22.1,Neuropathy peripheral,16876829
1,6,22.1,Thrombocytopenia,16876829
0,6,22.1,Bone marrow failure,16876849
1,6,22.1,Fatigue,16876849
2,6,22.1,Thrombocytopenia,16876849
3,6,22.1,Neutropenia,16876849
0,6,22.1,Neutrophil count decreased,16876850
1,6,22.1,Abdominal pain,16876850
2,6,22.1,Fatigue,16876850
3,6,22.1,Nausea,16876850
4,6,22.1,Alopecia,16876850
5,6,22.1,Vomiting,16876850
0,1,22.1,Dyspnoea at rest,16876855
1,1,22.1,Flushing,16876855
2,1,22.1,Burning sensation,16876855
0,5,22.1,Malignant neoplasm progression,16876858
1,6,22.1,Intentional product use issue,16876858
0,2,22.1,Interstitial lung disease,16876868
0,2,22.1,Inflammation,16876941
1,2,22.1,Abdominal pain upper,16876941
2,2,22.1,Carbohydrate antigen 15-3 increased,16876941
3,2,22.1,Decreased activity,16876941
4,2,22.1,Fatigue,16876941
5,2,22.1,Dysstasia,16876941
6,3,22.1,Drug ineffective,16876941
0,6,22.1,Malignant neoplasm progression,16876942
1,6,22.1,Acquired gene mutation,16876942
2,6,22.1,Drug resistance,16876942
0,6,22.1,Malignant neoplasm progression,16876943
1,6,22.1,Drug resistance,16876943
0,6,22.1,Malignant neoplasm progression,16876945
1,6,22.1,Drug resistance,16876945
0,3,22.1,Pain,16876948
1,3,22.1,Gait inability,16876948
2,3,22.1,Carbohydrate antigen 15-3 increased,16876948
3,3,22.1,Bone pain,16876948
0,1,22.1,Bronchospasm,16876988
1,6,22.1,Off label use,16876988
2,1,22.1,Dysphonia,16876988
3,1,22.1,Dyspnoea,16876988
4,1,22.1,Chest discomfort,16876988
5,1,22.1,Hyperhidrosis,16876988
6,1,22.1,Flushing,16876988
7,1,22.1,Hypertension,16876988
8,1,22.1,Tachycardia,16876988
9,1,22.1,Oxygen saturation decreased,16876988
0,2,22.1,Dizziness,16877002
1,2,22.1,Blood pressure decreased,16877002
2,2,22.1,Head discomfort,16877002
0,6,22.1,Renal impairment,16877008
0,6,22.1,Tumour haemorrhage,16877043
1,6,22.1,Neoplasm progression,16877043
0,6,22.1,Inappropriate schedule of product administration,16877062
1,5,22.1,Breast cancer metastatic,16877062
2,5,22.1,Malignant neoplasm progression,16877062
0,6,22.1,Osteonecrosis of jaw,16877098
0,6,22.1,Off label use,16877110
0,6,22.1,Weight decreased,16877132
1,1,22.1,Clostridium difficile colitis,16877132
0,5,22.1,Pulmonary embolism,16877181
0,5,22.1,Death,16877185
0,6,22.1,Gastric disorder,16877209
1,6,22.1,Laboratory test abnormal,16877209
2,6,22.1,Haematemesis,16877209
3,6,22.1,Urinary sediment present,16877209
0,,22.1,Protein urine present,16877239
0,1,22.1,Right atrial enlargement,16877293
1,1,22.1,Aortic valve incompetence,16877293
2,1,22.1,Ejection fraction decreased,16877293
3,1,22.1,Pericardial effusion,16877293
4,1,22.1,Sinus bradycardia,16877293
5,6,22.1,Tricuspid valve incompetence,16877293
6,1,22.1,Pulmonary arterial pressure increased,16877293
7,1,22.1,Left atrial enlargement,16877293
8,6,22.1,Electrocardiogram QT prolonged,16877293
9,6,22.1,Mitral valve incompetence,16877293
10,1,22.1,Supraventricular extrasystoles,16877293
11,1,22.1,Left ventricular enlargement,16877293
12,1,22.1,Sinus tachycardia,16877293
13,1,22.1,Pulmonary hypertension,16877293
14,1,22.1,Atrioventricular block,16877293
15,1,22.1,Left ventricular dysfunction,16877293
0,3,22.1,Gastric ulcer haemorrhage,16877307
1,3,22.1,Alopecia,16877307
2,2,22.1,Fatigue,16877307
3,3,22.1,Fatigue,16877307
0,6,22.1,Malignant neoplasm progression,16877319
1,6,22.1,Drug resistance,16877319
0,3,22.1,Constipation,16877336
1,3,22.1,Abdominal pain,16877336
0,3,22.1,Hair disorder,16877349
1,3,22.1,Alopecia,16877349
2,3,22.1,Hair texture abnormal,16877349
3,3,22.1,Madarosis,16877349
4,3,22.1,Hair colour changes,16877349
0,6,22.1,Colorectal cancer metastatic,16877355
1,2,22.1,Rash pruritic,16877355
0,6,22.1,Dizziness,16877356
1,6,22.1,Confusional state,16877356
2,6,22.1,Hypotension,16877356
0,6,22.1,Vomiting,16877363
1,6,22.1,Nausea,16877363
0,6,22.1,General physical health deterioration,16877369
0,6,22.1,Malaise,16877371
1,2,22.1,White blood cell count decreased,16877371
2,2,22.1,Gastrooesophageal reflux disease,16877371
0,2,22.1,Gait disturbance,16877410
0,6,22.1,Hot flush,16877432
1,6,22.1,Arthralgia,16877432
2,6,22.1,Myalgia,16877432
3,6,22.1,Vulvovaginal dryness,16877432
0,1,22.1,Pulmonary thrombosis,16877438
1,1,22.1,Abdominal pain upper,16877438
2,1,22.1,Gastric disorder,16877438
3,1,22.1,Diarrhoea,16877438
0,2,22.1,Amaurosis,16877447
1,6,22.1,Product use in unapproved indication,16877447
2,2,22.1,Dizziness,16877447
3,6,22.1,Off label use,16877447
0,6,22.1,Neoplasm progression,16877463
1,6,22.1,Skin exfoliation,16877463
2,6,22.1,Peripheral swelling,16877463
3,6,22.1,Speech disorder,16877463
4,6,22.1,Dry skin,16877463
5,6,22.1,Alopecia,16877463
6,6,22.1,Hair texture abnormal,16877463
7,6,22.1,Weight fluctuation,16877463
8,6,22.1,Pruritus,16877463
9,6,22.1,Joint swelling,16877463
10,6,22.1,Hypoaesthesia,16877463
0,6,22.1,Flank pain,16877478
1,6,22.1,Acute kidney injury,16877478
2,6,22.1,Renal tubular necrosis,16877478
3,6,22.1,Renal mass,16877478
4,6,22.1,Fatigue,16877478
5,6,22.1,Blood creatinine increased,16877478
6,6,22.1,Seizure,16877478
0,5,22.1,Renal failure,16877481
1,5,22.1,Dehydration,16877481
0,6,22.1,Off label use,16877488
1,1,22.1,Infected cyst,16877488
0,6,22.1,Metastases to lung,16877489
1,1,22.1,Neutrophil count decreased,16877489
2,6,22.1,Metastases to liver,16877489
0,6,22.1,Abdominal discomfort,16877502
1,6,22.1,Asthenia,16877502
2,6,22.1,Confusional state,16877502
3,6,22.1,Decreased appetite,16877502
4,6,22.1,Dry skin,16877502
5,6,22.1,Amnesia,16877502
6,6,22.1,Cognitive disorder,16877502
0,6,22.1,Neoplasm progression,16877505
0,6,22.1,Paraesthesia oral,16877506
1,6,22.1,Insomnia,16877506
2,6,22.1,Decreased appetite,16877506
3,6,22.1,Pruritus,16877506
4,6,22.1,Aphonia,16877506
5,6,22.1,Buccal mucosal roughening,16877506
6,6,22.1,Oral discomfort,16877506
7,6,22.1,Ageusia,16877506
8,6,22.1,Dysphonia,16877506
0,3,22.1,Hair texture abnormal,16877516
1,3,22.1,Hair colour changes,16877516
2,3,22.1,Alopecia,16877516
3,3,22.1,Hair disorder,16877516
4,3,22.1,Madarosis,16877516
0,6,22.1,Blood count abnormal,16877517
0,6,22.1,Full blood count decreased,16877519
0,6,22.1,Fatigue,16877522
0,3,22.1,Fatigue,16877533
1,3,22.1,Pain,16877533
0,3,22.1,Pathological fracture,16877574
0,6,22.1,Metastases to bone,16877581
1,6,22.1,Pain in extremity,16877581
2,6,22.1,Memory impairment,16877581
3,6,22.1,Asthenia,16877581
4,6,22.1,Drug ineffective,16877581
5,3,22.1,Vomiting,16877581
6,6,22.1,Injury,16877581
7,6,22.1,Gait disturbance,16877581
8,6,22.1,Nausea,16877581
9,6,22.1,Renal impairment,16877581
10,6,22.1,Drug intolerance,16877581
11,6,22.1,Pain,16877581
12,6,22.1,Drug resistance,16877581
13,6,22.1,Somnolence,16877581
14,6,22.1,Muscle strain,16877581
15,6,22.1,Thrombocytopenia,16877581
16,6,22.1,Metastasis,16877581
17,6,22.1,Metastases to spine,16877581
18,6,22.1,Urinary retention,16877581
19,6,22.1,Malnutrition,16877581
20,6,22.1,Movement disorder,16877581
21,6,22.1,Visual impairment,16877581
22,6,22.1,Migraine,16877581
23,6,22.1,Swelling,16877581
24,6,22.1,Constipation,16877581
25,5,22.1,Death,16877581
26,6,22.1,Hypoacusis,16877581
27,6,22.1,Speech disorder,16877581
28,6,22.1,Hypophagia,16877581
29,6,22.1,Malaise,16877581
30,6,22.1,Hyperhidrosis,16877581
31,6,22.1,Weight decreased,16877581
0,5,22.1,Death,16877591
0,1,22.1,Neoplasm progression,16877631
0,6,22.1,Fatigue,16877640
1,6,22.1,Neutrophil count decreased,16877640
0,2,22.1,Blood count abnormal,16877650
0,6,22.1,Dyspnoea,16877656
0,5,22.1,Death,16877658
1,6,22.1,Malignant neoplasm progression,16877658
2,2,22.1,Nausea,16877658
3,6,22.1,Intentional product use issue,16877658
4,2,22.1,Diarrhoea,16877658
5,2,22.1,Vomiting,16877658
0,6,22.1,Abdominal discomfort,16877668
1,6,22.1,Nausea,16877668
2,6,22.1,Ageusia,16877668
3,6,22.1,Parosmia,16877668
4,6,22.1,Taste disorder,16877668
5,6,22.1,Abdominal distension,16877668
0,,22.1,Rash pruritic,16877688
1,,22.1,Rash macular,16877688
0,5,22.1,Death,16877696
0,5,22.1,Death,16877698
0,6,22.1,Arthralgia,16877715
1,6,22.1,Peripheral swelling,16877715
2,6,22.1,Oedema peripheral,16877715
3,6,22.1,Immune-mediated adverse reaction,16877715
0,6,22.1,Radiation pneumonitis,16877733
0,3,22.1,Thyroid hormones decreased,16877746
1,6,22.1,Contusion,16877746
2,6,22.1,Localised infection,16877746
3,6,22.1,Osteoarthritis,16877746
0,5,22.1,Death,16877773
0,5,22.1,Death,16877780
1,6,22.1,Ascites,16877780
2,6,22.1,Sepsis,16877780
3,6,22.1,Dry mouth,16877780
4,6,22.1,Chapped lips,16877780
5,6,22.1,Infection,16877780
6,6,22.1,Lip swelling,16877780
7,6,22.1,Condition aggravated,16877780
8,6,22.1,Full blood count decreased,16877780
9,6,22.1,Nausea,16877780
10,6,22.1,Throat irritation,16877780
11,6,22.1,Dysphagia,16877780
12,6,22.1,Oesophageal pain,16877780
0,6,22.1,Weight decreased,16877807
1,1,22.1,Pyrexia,16877807
2,6,22.1,Vomiting,16877807
3,6,22.1,Injection site bruising,16877807
4,1,22.1,Dehydration,16877807
5,2,22.1,Abdominal discomfort,16877807
6,6,22.1,Insomnia,16877807
7,1,22.1,Hypertension,16877807
8,6,22.1,Nausea,16877807
0,3,22.1,Fatigue,16877838
1,3,22.1,Sciatica,16877838
2,3,22.1,Malignant neoplasm progression,16877838
3,3,22.1,Blood pressure decreased,16877838
4,3,22.1,Blood pressure increased,16877838
5,2,22.1,Pain,16877838
6,1,22.1,Weight decreased,16877838
7,3,22.1,Renal failure,16877838
8,3,22.1,Conjunctivitis,16877838
9,3,22.1,Decreased appetite,16877838
10,3,22.1,Skin ulcer,16877838
11,2,22.1,Incarcerated inguinal hernia,16877838
12,2,22.1,Blood pressure fluctuation,16877838
13,3,22.1,Mucosal inflammation,16877838
14,3,22.1,Palmar-plantar erythrodysaesthesia syndrome,16877838
15,3,22.1,Alopecia,16877838
0,6,22.1,Seizure,16877862
0,6,22.1,Adverse drug reaction,16877892
0,5,22.1,Death,16877896
0,1,22.1,Headache,16877902
1,1,22.1,Proctalgia,16877902
2,1,22.1,Vomiting,16877902
3,5,22.1,Prostate cancer,16877902
4,6,22.1,Dysuria,16877902
0,6,22.1,Prostate cancer,16877903
1,6,22.1,Pain,16877903
0,6,22.1,Malignant neoplasm progression,16877934
1,6,22.1,Drug resistance,16877934
2,1,22.1,Chest discomfort,16877934
0,5,22.1,Death,16878004
0,5,22.1,Death,16878008
0,6,22.1,Pain,16878038
1,6,22.1,Transfusion,16878038
0,5,22.1,Death,16878049
0,6,22.1,Lung disorder,16878077
1,6,22.1,Infection,16878077
2,6,22.1,Blood count abnormal,16878077
3,6,22.1,Blood sodium decreased,16878077
4,2,22.1,Weight decreased,16878077
0,5,22.1,Malignant neoplasm progression,16878084
1,1,22.1,Hypothyroidism,16878084
0,3,22.1,Memory impairment,16878093
1,3,22.1,Immune system disorder,16878093
0,6,22.1,Vomiting,16878095
1,6,22.1,Dysphagia,16878095
0,2,22.1,Monoparesis,16878148
1,2,22.1,Atrial fibrillation,16878148
2,2,22.1,Heart rate irregular,16878148
3,2,22.1,Tachypnoea,16878148
4,2,22.1,Oxygen saturation decreased,16878148
5,2,22.1,Wheezing,16878148
6,2,22.1,Blood pressure decreased,16878148
7,2,22.1,Tachycardia paroxysmal,16878148
8,2,22.1,Ventricular fibrillation,16878148
0,3,22.1,Eye oedema,16878164
1,3,22.1,Ocular hyperaemia,16878164
2,6,22.1,Product administration error,16878164
0,6,22.1,Memory impairment,16878201
0,1,22.1,Neutropenia,16878243
1,6,22.1,Pleural effusion,16878243
2,6,22.1,Malignant neoplasm progression,16878243
3,1,22.1,Electrocardiogram QT prolonged,16878243
4,1,22.1,Renal impairment,16878243
5,3,22.1,Metastases to pleura,16878243
6,6,22.1,Invasive ductal breast carcinoma,16878243
0,6,22.1,Recurrent cancer,16878321
1,6,22.1,Gastrointestinal viral infection,16878321
2,6,22.1,Rhinorrhoea,16878321
3,3,22.1,Blood creatinine increased,16878321
4,6,22.1,Kidney small,16878321
5,3,22.1,Carbohydrate antigen 125 increased,16878321
6,6,22.1,Constipation,16878321
7,6,22.1,Blood pressure abnormal,16878321
8,1,22.1,Blood pressure increased,16878321
9,6,22.1,Nausea,16878321
10,1,22.1,Heart rate increased,16878321
11,6,22.1,Product dispensing error,16878321
0,6,22.1,Cognitive disorder,16878334
0,5,22.1,Death,16878347
0,1,22.1,Headache,16878348
1,1,22.1,Vomiting,16878348
2,3,22.1,Joint swelling,16878348
3,1,22.1,Dry mouth,16878348
4,1,22.1,Constipation,16878348
5,6,22.1,Nocturia,16878348
6,6,22.1,Off label use,16878348
7,3,22.1,Carbohydrate antigen 125 increased,16878348
8,1,22.1,Fatigue,16878348
9,1,22.1,Tension headache,16878348
10,6,22.1,Malignant neoplasm progression,16878348
11,1,22.1,Decreased appetite,16878348
12,6,22.1,Underdose,16878348
13,3,22.1,Platelet count decreased,16878348
14,1,22.1,Cough,16878348
15,1,22.1,Nausea,16878348
16,1,22.1,Dry throat,16878348
17,2,22.1,Insomnia,16878348
18,1,22.1,Blood pressure increased,16878348
0,6,22.1,Hepatitis C virus test positive,16878399
1,6,22.1,Cytomegalovirus infection,16878399
2,6,22.1,Herpes simplex,16878399
0,1,22.1,Portal hypertension,16878407
1,3,22.1,Hepatitis toxic,16878407
0,,22.1,Soft tissue necrosis,16878439
1,,22.1,Soft tissue infection,16878439
2,,22.1,Skin ulcer,16878439
0,6,22.1,Intentional product misuse,16878448
1,6,22.1,Rash,16878448
2,6,22.1,Dermatitis allergic,16878448
3,6,22.1,Product use in unapproved indication,16878448
0,6,22.1,Dry eye,16878486
1,6,22.1,Fatigue,16878486
2,6,22.1,White blood cell count decreased,16878486
3,6,22.1,Blood count abnormal,16878486
0,5,22.1,Death,16878521
0,6,22.1,Pulmonary toxicity,16878533
0,6,22.1,Oesophagitis,16878690
0,1,22.1,Pyrexia,16878696
1,1,22.1,Febrile neutropenia,16878696
2,1,22.1,Immune-mediated hepatitis,16878696
3,1,22.1,Rhinorrhoea,16878696
4,1,22.1,Pharyngotonsillitis,16878696
5,1,22.1,Productive cough,16878696
6,1,22.1,Cough,16878696
7,1,22.1,Dizziness,16878696
8,1,22.1,Fatigue,16878696
9,1,22.1,Oropharyngeal pain,16878696
10,1,22.1,Nasal dryness,16878696
0,6,22.1,Palmar erythema,16878710
0,3,22.1,Vomiting,16878745
1,3,22.1,Diarrhoea,16878745
2,3,22.1,Dry mouth,16878745
3,3,22.1,Fatigue,16878745
4,3,22.1,Decreased appetite,16878745
5,3,22.1,Somnolence,16878745
6,3,22.1,Constipation,16878745
7,3,22.1,Taste disorder,16878745
8,3,22.1,Weight decreased,16878745
0,3,22.1,Alopecia,16878756
0,3,22.1,Pneumonitis,16878768
1,6,22.1,Dysphonia,16878768
2,5,22.1,Malignant neoplasm progression,16878768
0,1,22.1,Neutrophil count decreased,16878813
1,2,22.1,Dermatitis acneiform,16878813
0,6,22.1,Off label use,16878816
1,3,22.1,Acute myeloid leukaemia,16878816
0,6,22.1,Pyrexia,16878817
0,1,22.1,Autoimmune hepatitis,16878820
1,6,22.1,Off label use,16878820
0,6,22.1,Tumour haemorrhage,16878821
0,2,22.1,Anal fissure,16878834
0,6,22.1,Red blood cell count decreased,16878882
1,2,22.1,Device related infection,16878882
2,1,22.1,Weight fluctuation,16878882
3,6,22.1,Nausea,16878882
4,3,22.1,Blood calcium increased,16878882
5,3,22.1,Fatigue,16878882
6,6,22.1,Chapped lips,16878882
7,6,22.1,Oral discomfort,16878882
8,6,22.1,White blood cell count decreased,16878882
9,3,22.1,Muscular weakness,16878882
10,1,22.1,Stomatitis,16878882
11,2,22.1,Hepatic enzyme increased,16878882
12,1,22.1,Blister,16878882
13,2,22.1,Glossodynia,16878882
0,1,22.1,Injection site pain,16878914
1,3,22.1,Dental fistula,16878914
2,1,22.1,Malaise,16878914
3,6,22.1,Injection site pain,16878914
4,6,22.1,Injection site induration,16878914
5,6,22.1,Injection site erythema,16878914
6,3,22.1,Osteomyelitis,16878914
7,1,22.1,Taste disorder,16878914
8,6,22.1,Off label use,16878914
9,6,22.1,Product use in unapproved indication,16878914
0,6,22.1,Malignant neoplasm progression,16879088
0,3,22.1,Autoimmune myocarditis,16879094
0,6,22.1,Dizziness,16879175
0,6,22.1,Vulvovaginal candidiasis,16879239
1,6,22.1,Vomiting,16879239
2,6,22.1,Stomatitis,16879239
3,6,22.1,Nausea,16879239
4,6,22.1,Diarrhoea,16879239
0,3,22.1,Taste disorder,16879265
1,1,22.1,Acute kidney injury,16879265
2,1,22.1,Lower respiratory tract infection,16879265
3,3,22.1,Constipation,16879265
4,1,22.1,Sciatica,16879265
5,3,22.1,Lymphoedema,16879265
6,3,22.1,Cough,16879265
7,3,22.1,Dysphagia,16879265
8,3,22.1,Fatigue,16879265
0,2,22.1,Anaemia,16879270
1,6,22.1,Product use in unapproved indication,16879270
0,5,22.1,Death,16879271
1,1,22.1,Osteomyelitis,16879271
2,2,22.1,Pain in jaw,16879271
3,3,22.1,Skin ulcer,16879271
4,2,22.1,Gingival ulceration,16879271
0,2,22.1,Oedema peripheral,16879383
1,3,22.1,Oesophageal stenosis,16879383
0,6,22.1,Neutropenia,16879388
1,6,22.1,Diarrhoea,16879388
2,6,22.1,Proteinuria,16879388
3,6,22.1,Small intestinal obstruction,16879388
4,6,22.1,Intestinal perforation,16879388
5,6,22.1,Hypertension,16879388
6,6,22.1,Thrombocytopenia,16879388
7,6,22.1,Gastrointestinal haemorrhage,16879388
8,6,22.1,Febrile neutropenia,16879388
9,6,22.1,Nausea,16879388
10,6,22.1,Fatigue,16879388
0,1,22.1,Stoma site haemorrhage,16879439
1,6,22.1,Iron deficiency anaemia,16879439
0,1,22.1,Dyspnoea,16879499
1,6,22.1,Asthma,16879499
0,6,22.1,Platelet count decreased,16879527
1,6,22.1,Hepatic enzyme increased,16879527
0,6,22.1,Bone marrow failure,16879541
0,6,22.1,Hepatic failure,16879542
1,6,22.1,White blood cell count decreased,16879542
2,6,22.1,Neoplasm progression,16879542
3,5,22.1,Platelet count decreased,16879542
4,5,22.1,Liver function test increased,16879542
5,6,22.1,Interstitial lung disease,16879542
6,6,22.1,Red blood cell count decreased,16879542
7,5,22.1,Melaena,16879542
8,6,22.1,Haemoglobin decreased,16879542
9,5,22.1,Disseminated intravascular coagulation,16879542
10,5,22.1,Pancytopenia,16879542
11,6,22.1,Delirium,16879542
0,2,22.1,Bone marrow failure,16879748
0,6,22.1,Hypertension,16879755
1,6,22.1,Renal failure,16879755
2,5,22.1,Death,16879755
3,6,22.1,Diabetes mellitus,16879755
4,6,22.1,Neoplasm progression,16879755
0,1,22.1,Drug interaction,16879763
1,1,22.1,Somnolence,16879763
0,6,22.1,Ventricular extrasystoles,16879772
1,6,22.1,Myocardial ischaemia,16879772
2,6,22.1,Atrial fibrillation,16879772
3,2,22.1,Cardiac failure,16879772
0,2,22.1,Hypothyroidism,16879775
1,6,22.1,Drug ineffective,16879775
2,6,22.1,Pneumonitis,16879775
3,2,22.1,Pneumonia,16879775
0,1,22.1,Thrombocytopenia,16879795
1,6,22.1,Drug ineffective,16879795
2,1,22.1,Febrile neutropenia,16879795
3,1,22.1,Hepatic enzyme increased,16879795
4,3,22.1,Hyperthyroidism,16879795
0,6,22.1,Drug interaction,16879856
1,2,22.1,Gastrointestinal haemorrhage,16879856
2,6,22.1,Post procedural haemorrhage,16879856
0,6,22.1,Febrile neutropenia,16879920
0,2,22.1,Bone marrow failure,16879931
1,2,22.1,Hepatic function abnormal,16879931
0,6,22.1,Septic shock,16879940
1,5,22.1,Drug interaction,16879940
2,6,22.1,Rash,16879940
3,6,22.1,Vomiting,16879940
4,6,22.1,Stevens-Johnson syndrome,16879940
5,6,22.1,Thrombocytopenia,16879940
6,6,22.1,Leukopenia,16879940
7,6,22.1,Mucosal inflammation,16879940
8,6,22.1,Diarrhoea,16879940
0,6,22.1,Arthralgia,16879954
1,6,22.1,Nightmare,16879954
2,6,22.1,Ankle operation,16879954
3,6,22.1,Bone pain,16879954
4,6,22.1,Off label use,16879954
5,6,22.1,Fatigue,16879954
0,6,22.1,Device breakage,16879967
1,6,22.1,Off label use,16879967
0,1,22.1,Diarrhoea,16880052
1,1,22.1,Pyrexia,16880052
2,1,22.1,Agranulocytosis,16880052
0,5,22.1,Death,16880063
0,6,22.1,Metastasis,16880064
0,6,22.1,Seizure,16880098
1,6,22.1,Off label use,16880098
0,6,22.1,Hypertension,16880099
1,6,22.1,Diarrhoea,16880099
2,6,22.1,Fatigue,16880099
3,6,22.1,Lower gastrointestinal haemorrhage,16880099
4,6,22.1,Off label use,16880099
5,6,22.1,Myalgia,16880099
0,3,22.1,Platelet count decreased,16880117
1,6,22.1,Hepatotoxicity,16880117
0,3,22.1,Pleurisy,16880153
1,6,22.1,Anaemia,16880153
2,5,22.1,Respiratory acidosis,16880153
3,1,22.1,Febrile bone marrow aplasia,16880153
4,5,22.1,Dyspnoea,16880153
5,6,22.1,Dyspnoea,16880153
6,6,22.1,Neutropenia,16880153
0,6,22.1,Drug interaction,16880269
1,1,22.1,Diarrhoea,16880269
0,1,22.1,Nausea,16880273
1,6,22.1,Drug interaction,16880273
2,1,22.1,Asthenia,16880273
3,1,22.1,Dermatitis,16880273
4,1,22.1,Neutropenia,16880273
0,1,22.1,Hypocalcaemia,16880287
1,2,22.1,Decreased appetite,16880287
2,1,22.1,Blood creatine phosphokinase increased,16880287
3,2,22.1,Hypomagnesaemia,16880287
0,5,22.1,Hepatic ischaemia,16880330
1,5,22.1,Gastrointestinal ischaemia,16880330
0,1,22.1,Weight decreased,16880356
1,1,22.1,Renal impairment,16880356
0,6,22.1,Muscular weakness,16880471
0,3,22.1,Fatigue,16880473
1,3,22.1,Oropharyngeal pain,16880473
2,3,22.1,Weight decreased,16880473
3,3,22.1,Taste disorder,16880473
4,3,22.1,Decreased appetite,16880473
5,3,22.1,Fall,16880473
6,1,22.1,Blood pressure systolic increased,16880473
7,3,22.1,Insomnia,16880473
8,3,22.1,Asthenia,16880473
9,3,22.1,Feeling cold,16880473
10,3,22.1,Nervousness,16880473
11,3,22.1,Cough,16880473
12,3,22.1,Abdominal distension,16880473
13,3,22.1,Nausea,16880473
14,3,22.1,Depression,16880473
0,5,22.1,Renal failure,16880475
0,2,22.1,Palmar-plantar erythrodysaesthesia syndrome,16880484
1,1,22.1,Enterocolitis,16880484
0,1,22.1,Abdominal pain,16880490
0,3,22.1,Diplopia,16880508
0,2,22.1,Mechanical ileus,16880510
1,2,22.1,Bone marrow failure,16880510
0,1,22.1,Alanine aminotransferase increased,16880515
0,,22.1,Disease progression,16880529
0,,22.1,Nausea,16880535
1,,22.1,Visual impairment,16880535
0,2,22.1,Skin fissures,16880536
1,2,22.1,Asthenia,16880536
2,2,22.1,Vomiting,16880536
3,2,22.1,Paraesthesia,16880536
0,6,22.1,Nausea,16880548
1,6,22.1,Alopecia,16880548
2,6,22.1,Vomiting,16880548
3,6,22.1,Face oedema,16880548
4,6,22.1,Bone marrow failure,16880548
0,5,22.1,Death,16880563
1,6,22.1,Product use in unapproved indication,16880563
2,6,22.1,Burning sensation,16880563
3,6,22.1,Dysphagia,16880563
4,6,22.1,Stomatitis,16880563
0,6,22.1,Urinary tract infection,16880566
1,6,22.1,Dehydration,16880566
2,6,22.1,Blood pressure abnormal,16880566
3,6,22.1,Adverse event,16880566
4,6,22.1,Constipation,16880566
5,6,22.1,Transfusion,16880566
6,6,22.1,Pleural effusion,16880566
7,6,22.1,Fatigue,16880566
0,1,22.1,Pulmonary embolism,16880604
1,1,22.1,Shock haemorrhagic,16880604
0,6,22.1,Face oedema,16880609
1,6,22.1,Bone marrow failure,16880609
2,6,22.1,Nausea,16880609
3,6,22.1,Mouth ulceration,16880609
4,6,22.1,Alopecia,16880609
5,6,22.1,Vomiting,16880609
0,6,22.1,Cardiac failure,16880643
1,6,22.1,Ejection fraction decreased,16880643
2,6,22.1,Cardiotoxicity,16880643
3,6,22.1,Dyspnoea,16880643
0,1,22.1,Hypokalaemia,16880644
1,1,22.1,Thrombocytopenia,16880644
2,3,22.1,Nausea,16880644
3,1,22.1,Procedural pain,16880644
4,1,22.1,Gamma-glutamyltransferase increased,16880644
5,6,22.1,Sleep disorder,16880644
6,6,22.1,Blood creatinine increased,16880644
0,6,22.1,Seizure,16880648
1,3,22.1,Acute disseminated encephalomyelitis,16880648
2,3,22.1,Demyelination,16880648
0,1,22.1,Heart rate irregular,16880723
1,1,22.1,Panic attack,16880723
2,3,22.1,Decreased appetite,16880723
3,3,22.1,Constipation,16880723
4,1,22.1,Blood pressure fluctuation,16880723
5,3,22.1,Asthenia,16880723
0,6,22.1,Malignant neoplasm progression,16880740
1,6,22.1,Drug resistance,16880740
0,1,22.1,Malaise,16880761
1,6,22.1,Constipation,16880761
2,6,22.1,Nervousness,16880761
3,6,22.1,Fatigue,16880761
4,6,22.1,Pyrexia,16880761
0,3,22.1,Neoplasm progression,16880771
0,5,22.1,Sudden death,16880800
1,6,22.1,Off label use,16880800
2,1,22.1,Acute kidney injury,16880800
0,5,22.1,Acute hepatic failure,16880817
1,3,22.1,Autoimmune hepatitis,16880817
2,6,22.1,Off label use,16880817
0,6,22.1,Pain,16880820
1,6,22.1,Nausea,16880820
0,5,22.1,Death,16880839
0,1,22.1,Pneumonia,16880843
1,1,22.1,Pneumonia,16880843
0,6,22.1,White blood cell count decreased,16880846
0,6,22.1,Malaise,16880855
0,1,22.1,Autoimmune hepatitis,16880858
0,3,22.1,Pulmonary embolism,16880859
0,5,22.1,Death,16880860
0,,22.1,Pancreatitis,16880882
1,,22.1,Product dose omission,16880882
0,5,22.1,Pneumonia aspiration,16880883
0,6,22.1,Weight increased,16880887
0,3,22.1,Nasopharyngitis,16880896
1,3,22.1,Influenza like illness,16880896
0,2,22.1,Myocardial ischaemia,16880906
0,6,22.1,Hepatic enzyme decreased,16880910
1,6,22.1,Bile duct obstruction,16880910
2,6,22.1,Chromaturia,16880910
3,6,22.1,Flatulence,16880910
4,6,22.1,Jaundice,16880910
5,6,22.1,Vulvovaginal discomfort,16880910
6,6,22.1,Diarrhoea,16880910
7,6,22.1,Gallbladder disorder,16880910
8,6,22.1,Pancreatic disorder,16880910
9,6,22.1,Liver disorder,16880910
10,6,22.1,Malignant neoplasm progression,16880910
0,6,22.1,Cerebrovascular accident,16880911
0,6,22.1,Malignant neoplasm progression,16880920
0,1,22.1,Chronic obstructive pulmonary disease,16880933
0,3,22.1,Interstitial lung disease,16880946
1,3,22.1,Pneumonitis,16880946
0,2,22.1,Colitis ischaemic,16880956
1,2,22.1,Neutropenia,16880956
0,5,22.1,Death,16881017
0,6,22.1,Nasopharyngitis,16881024
0,3,22.1,Food craving,16881034
1,6,22.1,Nausea,16881034
0,3,22.1,Chills,16881044
1,3,22.1,Pyrexia,16881044
2,6,22.1,Pain,16881044
3,6,22.1,Feeling hot,16881044
4,3,22.1,Fatigue,16881044
5,3,22.1,Headache,16881044
0,6,22.1,Intentional product use issue,16881074
1,6,22.1,Haemorrhagic disorder,16881074
2,6,22.1,Renal disorder,16881074
0,6,22.1,Mucosal inflammation,16881086
1,3,22.1,Sepsis,16881086
2,3,22.1,General physical condition abnormal,16881086
3,6,22.1,Nausea,16881086
4,6,22.1,Vomiting,16881086
5,3,22.1,Renal impairment,16881086
6,3,22.1,Thrombocytopenia,16881086
7,3,22.1,Vitamin K decreased,16881086
8,6,22.1,Malignant neoplasm progression,16881086
9,6,22.1,Erythema,16881086
10,5,22.1,Hepatocellular injury,16881086
11,3,22.1,Neutropenia,16881086
12,6,22.1,Palmar-plantar erythrodysaesthesia syndrome,16881086
13,3,22.1,Hepatic function abnormal,16881086
14,6,22.1,Decreased appetite,16881086
15,6,22.1,Dermatitis exfoliative generalised,16881086
16,6,22.1,General physical health deterioration,16881086
17,6,22.1,Intraductal proliferative breast lesion,16881086
0,1,22.1,Atrial fibrillation,16881100
0,1,22.1,Musculoskeletal pain,16881172
0,6,22.1,Hypercalcaemia,16881182
1,6,22.1,Dental operation,16881182
2,6,22.1,Osteonecrosis of jaw,16881182
0,6,22.1,Decreased appetite,16881185
1,6,22.1,Blood potassium decreased,16881185
0,1,22.1,Tubulointerstitial nephritis,16881191
0,3,22.1,Tendon rupture,16881208
0,6,22.1,Diaphragmalgia,16881211
1,6,22.1,Anger,16881211
2,6,22.1,Product dose omission,16881211
3,6,22.1,Pain,16881211
4,6,22.1,Inappropriate schedule of product administration,16881211
5,6,22.1,Decreased activity,16881211
6,6,22.1,Nausea,16881211
7,6,22.1,Disease progression,16881211
8,6,22.1,White blood cell count abnormal,16881211
0,,22.1,Malaise,16881224
1,,22.1,Pyrexia,16881224
2,,22.1,Tachycardia,16881224
3,2,22.1,Chromaturia,16881224
4,,22.1,Dysphonia,16881224
0,,22.1,Fatigue,16881230
0,,22.1,Drug intolerance,16881255
0,5,22.1,Pneumonitis,16881265
1,6,22.1,Toxicity to various agents,16881265
0,6,22.1,Hypomagnesaemia,16881271
1,6,22.1,Toxicity to various agents,16881271
2,5,22.1,Haemorrhage intracranial,16881271
3,6,22.1,Headache,16881271
0,3,22.1,Anaemia,16881277
1,1,22.1,Bronchospasm,16881277
0,1,22.1,Pancytopenia,16881285
1,1,22.1,Renal failure,16881285
0,3,22.1,Ulcerative keratitis,16881292
0,1,22.1,Fatigue,16881303
0,1,22.1,Diverticulitis,16881321
0,3,22.1,Urinary retention,16881322
0,5,22.1,Respiratory failure,16881327
1,6,22.1,Hypocalcaemia,16881327
2,6,22.1,Pleural effusion,16881327
3,6,22.1,Dehydration,16881327
4,6,22.1,Pneumonia,16881327
5,6,22.1,Muscular weakness,16881327
6,6,22.1,Neutropenia,16881327
7,6,22.1,Toxicity to various agents,16881327
0,2,22.1,Weight increased,16881338
1,2,22.1,Flatulence,16881338
2,2,22.1,Faeces hard,16881338
3,2,22.1,Alopecia,16881338
4,2,22.1,Faeces discoloured,16881338
5,2,22.1,Hot flush,16881338
0,,22.1,Intercepted product preparation error,16881343
1,,22.1,Wrong technique in product usage process,16881343
2,,22.1,Product physical consistency issue,16881343
0,,22.1,Product preparation issue,16881369
1,,22.1,Intercepted product preparation error,16881369
0,6,22.1,Off label use,16881384
0,3,22.1,Hot flush,16881393
0,5,22.1,Metastatic neoplasm,16881400
0,5,22.1,Myocardial infarction,16881404
0,,22.1,Injury associated with device,16881411
1,,22.1,Needle issue,16881411
2,,22.1,Accidental exposure to product,16881411
0,6,22.1,Terminal state,16881414
0,1,22.1,Injection site erosion,16881420
1,3,22.1,Injection site bruising,16881420
2,1,22.1,Injection site mass,16881420
3,3,22.1,Injection site swelling,16881420
4,2,22.1,Injection site scar,16881420
5,6,22.1,Injection site haemorrhage,16881420
6,2,22.1,Injection site erythema,16881420
0,1,22.1,Febrile neutropenia,16881462
0,1,22.1,Constipation,16881499
1,1,22.1,Hydronephrosis,16881499
2,1,22.1,Pleural effusion,16881499
3,1,22.1,Pulmonary embolism,16881499
4,1,22.1,Ascites,16881499
5,1,22.1,Fatigue,16881499
6,1,22.1,Oedema,16881499
7,1,22.1,Compression fracture,16881499
8,1,22.1,Pain,16881499
9,1,22.1,Confusional state,16881499
10,1,22.1,Chest discomfort,16881499
11,1,22.1,Infection,16881499
12,1,22.1,Acute kidney injury,16881499
13,1,22.1,Lethargy,16881499
14,1,22.1,Renal impairment,16881499
15,1,22.1,Chest pain,16881499
16,1,22.1,Delirium,16881499
17,1,22.1,Dyspnoea,16881499
18,1,22.1,Neoplasm progression,16881499
19,1,22.1,Oedema peripheral,16881499
20,1,22.1,Toxicity to various agents,16881499
21,1,22.1,Urinary tract infection,16881499
0,1,22.1,Haematochezia,16881521
0,6,22.1,Constipation,16881589
1,6,22.1,Full blood count decreased,16881589
2,6,22.1,Flatulence,16881589
3,6,22.1,Muscle spasms,16881589
4,6,22.1,Peripheral swelling,16881589
0,6,22.1,Pain,16881615
1,6,22.1,Pyrexia,16881615
0,6,22.1,Nausea,16881634
1,6,22.1,Vomiting,16881634
2,6,22.1,Dizziness,16881634
3,6,22.1,Anaemia,16881634
4,6,22.1,Bone pain,16881634
5,6,22.1,Constipation,16881634
0,1,22.1,Acute kidney injury,16881636
1,1,22.1,Tumour lysis syndrome,16881636
0,3,22.1,Hair colour changes,16881647
1,3,22.1,Madarosis,16881647
2,6,22.1,Insomnia,16881647
3,6,22.1,Attention deficit/hyperactivity disorder,16881647
4,3,22.1,Alopecia,16881647
5,3,22.1,Hair disorder,16881647
6,3,22.1,Hair texture abnormal,16881647
7,6,22.1,Anxiety,16881647
0,3,22.1,Pleural effusion,16881650
1,3,22.1,Nausea,16881650
2,6,22.1,Overdose,16881650
3,6,22.1,Alopecia,16881650
4,3,22.1,Fatigue,16881650
0,5,22.1,Drug ineffective,16881678
0,5,22.1,Death,16881743
1,6,22.1,Dysphagia,16881743
2,6,22.1,Tubulointerstitial nephritis,16881743
3,6,22.1,Acute kidney injury,16881743
4,6,22.1,Off label use,16881743
0,5,22.1,Acute kidney injury,16881762
0,6,22.1,Drug resistance,16881845
1,6,22.1,Malignant neoplasm progression,16881845
0,2,22.1,Venous thrombosis limb,16881857
0,6,22.1,Tracheomalacia,16881887
1,1,22.1,Pneumonia,16881887
0,2,22.1,Bacterial infection,16881915
0,1,22.1,Weight decreased,16881924
1,1,22.1,Enteritis necroticans,16881924
2,1,22.1,Feeding disorder,16881924
3,1,22.1,Oesophagitis haemorrhagic,16881924
0,1,22.1,Prostate cancer metastatic,16881932
1,6,22.1,Product dose omission,16881932
0,6,22.1,Drug ineffective,16881934
0,1,22.1,Tendonitis,16881955
0,5,22.1,Malignant peritoneal neoplasm,16881957
1,5,22.1,Ileus,16881957
2,5,22.1,Prostate cancer,16881957
0,1,22.1,Pyrexia,16881958
1,1,22.1,Duodenal ulcer,16881958
2,3,22.1,Alopecia,16881958
3,1,22.1,Nail ridging,16881958
4,3,22.1,Peripheral sensory neuropathy,16881958
5,1,22.1,Breast pain,16881958
6,1,22.1,Dyspnoea,16881958
7,1,22.1,Diarrhoea,16881958
8,1,22.1,Gastrointestinal infection,16881958
9,1,22.1,Haematochezia,16881958
10,1,22.1,Abdominal pain upper,16881958
11,4,22.1,Myalgia,16881958
12,1,22.1,Decreased appetite,16881958
0,5,22.1,Myocardial infarction,16881976
0,6,22.1,Spinal cord disorder,16881979
0,1,22.1,Hypercalcaemia,16881999
1,3,22.1,Osteonecrosis of jaw,16881999
2,3,22.1,Anaemia,16881999
0,2,22.1,Interstitial lung disease,16882037
0,5,22.1,Malignant neoplasm progression,16882049
0,6,22.1,Dehydration,16882050
1,6,22.1,Abdominal pain,16882050
2,6,22.1,Malignant neoplasm progression,16882050
3,6,22.1,Drug ineffective,16882050
4,6,22.1,Diarrhoea,16882050
5,6,22.1,Vomiting,16882050
6,5,22.1,Death,16882050
7,6,22.1,Fatigue,16882050
0,,22.1,Anal haemorrhage,16882102
1,1,22.1,Melaena,16882102
2,5,22.1,Hormone-refractory prostate cancer,16882102
0,1,22.1,Thrombocytopenia,16882130
1,6,22.1,Inappropriate schedule of product administration,16882130
0,,22.1,Hospice care,16882150
0,,22.1,Therapy cessation,16882159
1,,22.1,Adverse drug reaction,16882159
2,,22.1,Fatigue,16882159
0,2,22.1,Skin cancer,16882161
0,6,22.1,Malignant neoplasm progression,16882181
1,6,22.1,General physical health deterioration,16882181
0,1,22.1,Insomnia,16882183
1,3,22.1,Blood alkaline phosphatase increased,16882183
2,1,22.1,Affective disorder,16882183
3,3,22.1,Anaemia,16882183
4,1,22.1,Logorrhoea,16882183
5,1,22.1,Delirium,16882183
0,2,22.1,Cardiac failure congestive,16882203
1,2,22.1,Drug intolerance,16882203
0,,22.1,Hospitalisation,16882218
0,2,22.1,Tongue ulceration,16882220
0,,22.1,Diarrhoea,16882223
0,,22.1,Hypoaesthesia,16882242
0,6,22.1,Bone cancer metastatic,16882278
1,6,22.1,Prostate cancer metastatic,16882278
0,5,22.1,Large intestine perforation,16882350
0,3,22.1,Pneumonia,16882505
0,5,22.1,Pneumonia bacterial,16882536
1,5,22.1,Interstitial lung disease,16882536
0,6,22.1,Intentional product use issue,16882558
1,5,22.1,Malignant neoplasm progression,16882558
0,6,22.1,Lung opacity,16882699
1,6,22.1,Metastases to central nervous system,16882699
2,6,22.1,Adrenal mass,16882699
3,6,22.1,Headache,16882699
4,6,22.1,Dyspnoea exertional,16882699
5,6,22.1,Fatigue,16882699
0,6,22.1,Thyroiditis,16882774
1,6,22.1,Bone marrow failure,16882774
2,6,22.1,Hypothyroidism,16882774
0,1,22.1,Pleural effusion,16882808
1,1,22.1,Neutropenia,16882808
2,1,22.1,Bradycardia,16882808
0,1,22.1,Leukopenia,16882820
1,1,22.1,Hypertensive crisis,16882820
2,1,22.1,Neutropenia,16882820
3,1,22.1,Oedema peripheral,16882820
0,3,22.1,Acute myeloid leukaemia,16882838
0,6,22.1,Intentional product use issue,16882858
1,5,22.1,Death,16882858
0,2,22.1,Bone marrow failure,16882896
0,2,22.1,Hypocalcaemia,16882996
0,2,22.1,Decreased appetite,16883010
1,1,22.1,Pneumothorax,16883010
2,6,22.1,Asthenia,16883010
3,1,22.1,Vomiting,16883010
4,6,22.1,Pleural effusion,16883010
5,6,22.1,Puncture site pain,16883010
6,3,22.1,Fatigue,16883010
7,1,22.1,Nausea,16883010
8,3,22.1,White blood cell count decreased,16883010
0,1,22.1,Renal failure,16883033
1,1,22.1,Fluid retention,16883033
0,2,22.1,Venous thrombosis limb,16883058
0,6,22.1,Focal nodular hyperplasia,16883072
0,2,22.1,Alopecia,16883145
0,2,22.1,Alopecia,16883146
0,1,22.1,Thrombocytopenia,16883159
1,1,22.1,Bicytopenia,16883159
2,1,22.1,Anaemia,16883159
0,2,22.1,Alopecia,16883230
0,3,22.1,Pruritus,16883235
1,3,22.1,Erythema,16883235
2,6,22.1,Psychological trauma,16883235
3,3,22.1,Dyspnoea,16883235
4,2,22.1,Alopecia,16883235
5,3,22.1,Blood pressure increased,16883235
0,2,22.1,Faecal calprotectin increased,16883319
1,2,22.1,Pneumonitis,16883319
2,2,22.1,Back pain,16883319
3,2,22.1,Horner^s syndrome,16883319
4,2,22.1,Blood thyroid stimulating hormone increased,16883319
5,1,22.1,Diarrhoea,16883319
6,2,22.1,Tachycardia,16883319
0,1,22.1,Myalgia,16883341
1,1,22.1,Arthralgia,16883341
0,3,22.1,Neurotoxicity,16883345
1,1,22.1,Neurotoxicity,16883345
0,2,22.1,Cytotoxic cardiomyopathy,16883427
1,1,22.1,Pulmonary hypertension,16883427
2,3,22.1,Cardiac failure,16883427
0,6,22.1,Acquired gene mutation,16883454
0,5,22.1,Pneumonitis,16883462
1,5,22.1,Dyspnoea,16883462
2,5,22.1,Acute respiratory failure,16883462
3,5,22.1,Pneumonia,16883462
0,6,22.1,Tubulointerstitial nephritis,16883476
0,1,22.1,Agranulocytosis,16883509
1,1,22.1,Diarrhoea,16883509
2,1,22.1,Pyrexia,16883509
0,6,22.1,Neutropenic sepsis,16883586
0,6,22.1,Urinary tract infection,16883588
0,2,22.1,Device related thrombosis,16883595
0,4,22.1,Haematuria,16883631
1,4,22.1,Abdominal pain lower,16883631
2,4,22.1,Urine output decreased,16883631
3,4,22.1,Abdominal distension,16883631
4,4,22.1,Vomiting,16883631
5,6,22.1,Pyelonephritis,16883631
6,6,22.1,Urinary tract infection,16883631
0,1,22.1,Mechanical ileus,16883633
1,1,22.1,Weight decreased,16883633
0,5,22.1,Malignant neoplasm progression,16883636
1,5,22.1,Therapeutic response decreased,16883636
2,5,22.1,Breast cancer,16883636
0,6,22.1,Drug resistance,16883654
1,6,22.1,Malignant neoplasm progression,16883654
0,2,22.1,Ileus,16883679
1,2,22.1,Pleural effusion,16883679
2,1,22.1,Pyelonephritis,16883679
3,5,22.1,Malignant neoplasm progression,16883679
0,6,22.1,Skin hypertrophy,16883704
1,6,22.1,Hypersomnia,16883704
2,6,22.1,Abdominal infection,16883704
3,6,22.1,Fatigue,16883704
4,6,22.1,Skin exfoliation,16883704
5,6,22.1,Blood pressure increased,16883704
6,6,22.1,Constipation,16883704
7,6,22.1,Pruritus,16883704
0,6,22.1,Breast cancer metastatic,16883734
0,3,22.1,Malignant neoplasm progression,16883736
1,3,22.1,Pleural effusion,16883736
2,3,22.1,Non-small cell lung cancer metastatic,16883736
0,6,22.1,Neoplasm progression,16883743
0,6,22.1,Weight decreased,16883749
1,6,22.1,Hypophagia,16883749
2,6,22.1,Depression,16883749
3,5,22.1,Death,16883749
0,6,22.1,Focal nodular hyperplasia,16883757
0,1,22.1,Bicytopenia,16883763
1,1,22.1,Anaemia,16883763
2,1,22.1,Thrombocytopenia,16883763
0,2,22.1,Pulmonary mycosis,16883765
1,2,22.1,Condition aggravated,16883765
2,2,22.1,Platelet count decreased,16883765
0,3,22.1,Oestrogen receptor assay positive,16883790
1,3,22.1,Uterine enlargement,16883790
2,3,22.1,Carbohydrate antigen 15-3 increased,16883790
3,3,22.1,Frequent bowel movements,16883790
4,3,22.1,Hepatic steatosis,16883790
5,3,22.1,Arthralgia,16883790
6,3,22.1,Clubbing,16883790
7,3,22.1,Dysuria,16883790
8,3,22.1,Abdominal lymphadenopathy,16883790
9,3,22.1,Back pain,16883790
10,3,22.1,Breast cancer metastatic,16883790
11,3,22.1,Palmar-plantar erythrodysaesthesia syndrome,16883790
12,3,22.1,Human epidermal growth factor receptor negative,16883790
13,3,22.1,Pelvic mass,16883790
14,3,22.1,Progesterone receptor assay positive,16883790
15,3,22.1,Uterine leiomyoma,16883790
16,3,22.1,Vertebral column mass,16883790
17,3,22.1,Metastases to liver,16883790
18,3,22.1,Ovarian mass,16883790
19,3,22.1,Urge incontinence,16883790
0,6,22.1,Hip fracture,16883793
0,6,22.1,Heart rate increased,16883826
1,6,22.1,Fatigue,16883826
2,6,22.1,Pancytopenia,16883826
3,6,22.1,Weight decreased,16883826
4,6,22.1,Chills,16883826
5,6,22.1,Pain,16883826
0,1,22.1,Viral pericarditis,16883836
0,6,22.1,Orthostatic hypotension,16883856
0,5,22.1,Death,16883873
0,3,22.1,Hormone-refractory prostate cancer,16884015
1,3,22.1,Metastases to bone,16884015
2,3,22.1,Diplopia,16884015
0,1,22.1,Hyperthermia,16884029
0,,22.1,Prostate cancer metastatic,16884039
1,3,22.1,General physical health deterioration,16884039
0,2,22.1,Peripheral swelling,16884045
0,5,22.1,Pneumonitis,16884095
0,3,22.1,Erythema induratum,16884166
1,1,22.1,Catheter site induration,16884166
0,1,22.1,Depressed level of consciousness,16884174
1,1,22.1,Abdominal pain upper,16884174
2,1,22.1,Visual impairment,16884174
3,1,22.1,Headache,16884174
0,3,22.1,Visual impairment,16884177
0,1,22.1,Stomatitis,16884224
1,1,22.1,Febrile neutropenia,16884224
0,3,22.1,Urticaria,16884225
1,3,22.1,Infusion related reaction,16884225
2,3,22.1,Hypertensive heart disease,16884225
0,2,22.1,Organising pneumonia,16884244
0,2,22.1,Autoimmune haemolytic anaemia,16884247
1,5,22.1,Malignant neoplasm progression,16884247
2,2,22.1,Arthritis,16884247
0,5,22.1,Malignant neoplasm progression,16884261
1,6,22.1,Anaemia,16884261
0,1,22.1,Clostridium difficile infection,16884262
0,1,22.1,Acute kidney injury,16884271
1,1,22.1,Hypocalcaemia,16884271
2,1,22.1,Hypokalaemia,16884271
3,1,22.1,Seizure,16884271
4,1,22.1,Hyponatraemia,16884271
5,1,22.1,Hypomagnesaemia,16884271
0,1,22.1,Gastrointestinal haemorrhage,16884288
0,3,22.1,Hospitalisation,16884413
1,6,22.1,Peripheral swelling,16884413
0,6,22.1,Catheter site induration,16884453
1,6,22.1,Infusion site extravasation,16884453
2,3,22.1,Erythema,16884453
0,6,22.1,Hypothyroidism,16884462
1,6,22.1,Pneumonitis,16884462
2,6,22.1,Pneumonia,16884462
0,6,22.1,Medication error,16884466
1,1,22.1,Hypertension,16884466
0,2,22.1,Staphylococcal infection,16884489
1,2,22.1,Pyrexia,16884489
2,1,22.1,Abscess,16884489
3,2,22.1,Candida infection,16884489
0,6,22.1,Aspartate aminotransferase increased,16884515
1,6,22.1,Platelet count decreased,16884515
2,1,22.1,Seizure,16884515
3,3,22.1,Hypoxia,16884515
4,2,22.1,Urinary tract infection,16884515
5,2,22.1,Pyrexia,16884515
6,6,22.1,Dysphonia,16884515
7,6,22.1,Pancytopenia,16884515
8,3,22.1,Dyspnoea,16884515
0,3,22.1,Chronic kidney disease,16884531
1,6,22.1,Anxiety,16884531
2,3,22.1,Gastrointestinal stromal tumour,16884531
3,6,22.1,Depression,16884531
0,1,22.1,Rash pruritic,16884546
1,1,22.1,Respiratory disorder,16884546
0,2,22.1,Anaemia,16884574
1,2,22.1,Pancytopenia,16884574
0,3,22.1,Face crushing,16884585
0,3,22.1,Dysarthria,16884596
1,1,22.1,Influenza,16884596
0,6,22.1,Drug resistance,16884613
1,6,22.1,Malignant neoplasm progression,16884613
0,6,22.1,Febrile neutropenia,16884671
1,6,22.1,Neutrophil count decreased,16884671
2,6,22.1,Fatigue,16884671
3,6,22.1,Stomatitis,16884671
4,6,22.1,Back pain,16884671
5,6,22.1,Diarrhoea,16884671
6,6,22.1,Nail infection,16884671
7,6,22.1,Peripheral sensory neuropathy,16884671
8,6,22.1,Nausea,16884671
9,6,22.1,Arthralgia,16884671
10,6,22.1,Nail dystrophy,16884671
11,6,22.1,Myalgia,16884671
0,6,22.1,Drug resistance,16884698
1,6,22.1,Malignant neoplasm progression,16884698
0,1,22.1,Alanine aminotransferase increased,16884706
1,1,22.1,Renal function test abnormal,16884706
2,6,22.1,Obliterative bronchiolitis,16884706
3,1,22.1,Pulmonary embolism,16884706
4,6,22.1,Deep vein thrombosis,16884706
5,1,22.1,Aspartate aminotransferase increased,16884706
0,,22.1,Blood sodium decreased,16884724
1,,22.1,Diarrhoea,16884724
0,1,22.1,Hepatocellular injury,16884801
0,5,22.1,Myocardial infarction,16884809
0,5,22.1,Death,16884834
0,,22.1,Pneumonia,16884873
0,2,22.1,Pneumonitis,16884891
0,2,22.1,Radiation pneumonitis,16884894
0,6,22.1,Product dose omission,16884895
1,6,22.1,Venous thrombosis,16884895
2,1,22.1,Interstitial lung disease,16884895
0,6,22.1,Pericardial effusion,16884899
1,1,22.1,Ejection fraction decreased,16884899
2,6,22.1,Rales,16884899
3,1,22.1,Brain natriuretic peptide increased,16884899
4,6,22.1,Malignant neoplasm progression,16884899
5,6,22.1,Tumour marker increased,16884899
6,6,22.1,Cardiac failure,16884899
7,6,22.1,Supraventricular extrasystoles,16884899
0,6,22.1,Drug resistance,16884901
1,2,22.1,Blood test abnormal,16884901
2,6,22.1,Malignant neoplasm progression,16884901
3,6,22.1,Metastases to central nervous system,16884901
0,3,22.1,Hypotension,16884914
0,6,22.1,Intestinal obstruction,16884990
1,6,22.1,Heart rate increased,16884990
2,6,22.1,Blood glucose decreased,16884990
3,6,22.1,Malaise,16884990
4,6,22.1,Diabetes mellitus,16884990
5,6,22.1,Unresponsive to stimuli,16884990
0,6,22.1,Malignant neoplasm progression,16884999
1,6,22.1,Drug resistance,16884999
0,3,22.1,Drug resistance,16885004
0,6,22.1,Herpes zoster,16885064
0,6,22.1,Asthenia,16885070
0,5,22.1,General physical health deterioration,16885096
0,6,22.1,Malignant neoplasm progression,16885117
1,6,22.1,Drug resistance,16885117
0,6,22.1,Cough,16885152
1,6,22.1,Nausea,16885152
